Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2021 | FLEX: real-world data platform bringing precision medicine to the clinic

Cynthia X. Ma • 7 Dec 2021
SABCS 2021
Breast Cancer
FLEX

Cynthia X. Ma, MD, PhD, Washington University in St. Louis, St. Louis, MO, talks on the FLEX real-world data platform (NCT03053193), an ongoing multicenter, prospective observational trial of a large, real-world dataset, combining whole genome expression with clinically annotated data, to accelerate research and discovery of subgroups in breast cancer. The goal of FLEX is to discover and develop novel genomic profiles that bring precision oncology to the clinic, and ultimately improve treatment and outcomes of patients with breast cancer. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

More from Cynthia X. Ma

The emerging role of AKT inhibitors in breast cancer
1:49
The emerging role of AKT inhibitors in breast cancer
Cynthia X. Ma • 13 Dec 2023
Novel PI3K inhibitors for breast cancer
2:55
Novel PI3K inhibitors for breast cancer
Cynthia X. Ma • 13 Dec 2023
Copanlisib and fulvestrant with abemaciclib in HER-, ER+ breast cancer
10:15
Copanlisib and fulvestrant with abemaciclib in HER-, ER+ breast cancer
Cynthia X. Ma • 13 Dec 2023
ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer
3:44
ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer
Cynthia X. Ma • 7 Dec 2021

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals